MyAverix Finance
NS · Healthcare
Vivanza Biosciences Ltd (530057)
Pharmaceuticals & Biotechnology
Vivanza Biosciences Ltd (530057) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $76.00M, P/E ratio is 21.11, net margin is -6.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 530057
Vivanza Biosciences Ltd (530057) — FAQ
What is Vivanza Biosciences Ltd's market cap?
Vivanza Biosciences Ltd (530057) has a reported market cap of $76.00M (data as of 2026-07-10).
What is 530057's P/E ratio?
The price-to-earnings (P/E) ratio for Vivanza Biosciences Ltd (530057) is 21.11 (data as of 2026-07-10).
Does Vivanza Biosciences Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Vivanza Biosciences Ltd (530057). Check the MyAverix Finance app for the latest dividend data.
What sector is Vivanza Biosciences Ltd in?
Vivanza Biosciences Ltd (530057) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 530057 listed on?
530057 is listed on NS.
What is Vivanza Biosciences Ltd's net margin?
Vivanza Biosciences Ltd (530057) reports a net margin of -6.9% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.